Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder
- PMID: 22433450
- PMCID: PMC3380099
- DOI: 10.1503/jpn.110109
Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder
Abstract
Background: Recent data from neuroimaging, genetic and clinical trials and animal models suggest a role for altered glutamatergic neuro transmission in the pathogenesis of obsessive-compulsive disorder (OCD). The aim of this study was to investigate whether variants in the GRIN2B gene, the gene encoding the NR2 subunit of the N-methyl-D-aspartate (NMDA) glutamate receptor, may contribute to genetic susceptibility to OCD or to different OCD subphenotypes.
Methods: Between 2003 and 2008, we performed a case-control association study in which we genotyped 10 tag single-nucleotide polymorphisms (SNPs) in the 3' untranslated region (3' UTR) of GRIN2B. We performed SNP association and haplotype analysis considering the OCD diagnosis and different OCD subphenotypes: early-onset OCD, comorbid tic disorders and OCD clinical symptom dimensions.
Results: We enrolled 225 patients with OCD and 279 controls recruited from the OCD Clinic at Bellvitge Hospital (Barcelona, Spain). No significant difference in the distribution of alleles or genotypes was detected between patients with OCD and controls. Nonetheless, on analyzing OCD subphenotypes, the rs1805476 SNP in male patients (95% confidence interval [CI] 1.37-4.22, p = 0.002) and a 4-SNP haplotype in the whole sample (rs1805476, rs1805501, rs1805502 and rs1805477; odds ratio 1.92, 95% CI 1.22-3.01; permutation p = 0.023) were significantly associated with the presence of contamination obsessions and cleaning compulsions.
Limitations: Study limitations included the risk of population stratification associated with the case-control design, use of psychiatrically unscreened blood donors as the control group, reduced sample size of participants with certain OCD subphenotypes and tested polymorphisms limited to 3' UTR and exon 13 of GRIN2B.
Conclusion: Our results converge with recent data suggesting a possible contribution of glutamatergic variants to the genetic vulnerability to OCD or at least to certain OCD manifestations. The dissection of OCD into more homogeneous subphenotypes may constitute a useful tool to disentangle the complex genetic basis of the disorder.
Figures

Similar articles
-
Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder.Psychoneuroendocrinology. 2011 May;36(4):473-83. doi: 10.1016/j.psyneuen.2010.07.022. Epub 2010 Sep 17. Psychoneuroendocrinology. 2011. PMID: 20850223
-
Lack of an association between obsessive-compulsive disorder and polymorphisms in the 3' untranslated region of GRIN2B in a Chinese Han population.Psychiatry Res. 2012 Mar 30;196(1):142-4. doi: 10.1016/j.psychres.2011.09.003. Psychiatry Res. 2012. PMID: 22578441
-
Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study.Psychopharmacology (Berl). 2004 Aug;174(4):530-8. doi: 10.1007/s00213-004-1847-1. Epub 2004 Apr 9. Psychopharmacology (Berl). 2004. PMID: 15083261
-
Obsessive-compulsive disorder, which genes? Which functions? Which pathways? An integrated holistic view regarding OCD and its complex genetic etiology.J Neurogenet. 2017 Sep;31(3):153-160. doi: 10.1080/01677063.2017.1336236. Epub 2017 Jun 13. J Neurogenet. 2017. PMID: 28608743 Review.
-
The need for inclusion of sex and age of onset variables in genetic association studies of obsessive-compulsive disorder: Overview.Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jun 3;67:107-16. doi: 10.1016/j.pnpbp.2016.01.012. Epub 2016 Jan 28. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 26827635 Review.
Cited by
-
Identification of a Novel Rat NR2B Subunit Gene Promoter Region Variant and Its Association with Microwave-Induced Neuron Impairment.Mol Neurobiol. 2016 May;53(4):2100-11. doi: 10.1007/s12035-015-9169-3. Epub 2015 Apr 28. Mol Neurobiol. 2016. PMID: 25917873
-
A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.Psychol Res Behav Manag. 2015 Apr 28;8:115-31. doi: 10.2147/PRBM.S58601. eCollection 2015. Psychol Res Behav Manag. 2015. PMID: 25995654 Free PMC article. Review.
-
Glutamatergic augmentation strategies in obsessive-compulsive disorder.Indian J Psychiatry. 2019 Jan;61(Suppl 1):S58-S65. doi: 10.4103/psychiatry.IndianJPsychiatry_520_18. Indian J Psychiatry. 2019. PMID: 30745678 Free PMC article. Review.
-
Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.Philos Trans R Soc Lond B Biol Sci. 2013 Feb 25;368(1615):20120435. doi: 10.1098/rstb.2012.0435. Print 2013. Philos Trans R Soc Lond B Biol Sci. 2013. PMID: 23440468 Free PMC article. Review.
-
Reduced Expression of the Htr2a, Grin1, and Bdnf Genes and Cognitive Inflexibility in a Model of High Compulsive Rats.Mol Neurobiol. 2023 Dec;60(12):6975-6991. doi: 10.1007/s12035-023-03506-5. Epub 2023 Jul 31. Mol Neurobiol. 2023. PMID: 37523044
References
-
- Saxena S, Rauch SL. Functional neuroimaging and the neuro-anatomy of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23:563–86. - PubMed
-
- Rosenberg DR, MacMaster FP, Keshavan MS, et al. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry. 2000;39:1096–103. - PubMed
-
- Whiteside SP, Port JD, Deacon BJ, et al. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res. 2006;146:137–47. - PubMed
-
- Rosenberg DR, Mirza Y, Russell A, et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry. 2004;43:1146–53. - PubMed